unknown
Stage
3
Investors
About
Zymeworks develops protein therapeutics and drug discovery platforms focused on innovative bispecific and multispecific antibody candidates to treat cancer and other diseases.
Explore Zymeworks's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.